
Pfizer Inc.
PFE 24.99 (-0.04%) 0.01
Health Care
Pharmaceuticals
Quality Checklist 3/8
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
5Y Shares Out Change < 0%
ROIC > 10%
Quick Ratio > 1
Past Net Income CAGR > 0%
Est. EPS Growth > 5%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $142.09(B)
EV: $189.33(B)
Total Equity: $93.10(B)
Earnings date: Feb-03-2026
P/E: 14.45
Forward P/E: 8.01
P/FCF: 13.73
P/S: 2.26
P/B: 1.53
EPS: $1.7
EPS (fwd): $3.1
FCF/share: $1.8
Revenue/share: $11.1
Book value/share: $16.3
ROIC: 6.3%
ROA: 4.6%
ROE: 10.6%
Debt/Equity: 0.67
Current Ratio: 1.30
Gross margin: 74.8%
Operating margin: 24.6%
Net margin: 15.7%
Dividend/share: $1.7
Div. yield: 6.80%
Growth Estimates
Revenue
CAGR: -3.8%FY+1$62.01(B)
FY+2(-1.3%)$61.20(B)
FY+3(-2.9%)$59.45(B)
FY+4(-6.1%)$55.80(B)
FY+5(-4.8%)$53.15(B)
Net Income
CAGR: -7.0%FY+1$17.91(B)
FY+2(-4.7%)$17.07(B)
FY+3(-3.5%)$16.47(B)
FY+4(-11.0%)$14.66(B)
FY+5(-8.5%)$13.42(B)
EPS
CAGR: -7.3%FY+1$3.12
FY+2(-3.5%)$3.01
FY+3(-4.0%)$2.89
FY+4(-12.1%)$2.54
FY+5(-9.4%)$2.30
FCF per share
CAGR: -0.7%FY+1$2.96
FY+2(+12.6%)$3.33
FY+3(-1.7%)$3.28
FY+4(-6.1%)$3.08
FY+5(-6.3%)$2.88
